Ovarian cancer biomarkers can be found in various tissue origins, including epithelial cells, the sex cord-stromal component, or germ cells. The majority of advanced-stage tumors are of epithelial ...

It should be noted that a combination of FDG-PET technology and validated serum biomarkers can enhance detection of recurrent ovarian cancer for patients. For example, elevated levels of CA-125 ...

High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced ...

Preliminary data by the start-up supported the hypothesis. A feasibility study examining the biomarker associated with ovarian cancer [CA125] in women with and without ovarian cancer delivered ...

In the final part of our interview, Alice W. Lee, PhD, MPH, highlights the importance of addressing ovarian cancer care disparities and beyond by understanding cultural and behavioral factors and ...

HRD-positive tumours HRD (homologous recombination deficiency) is an important biomarker of the most advanced stages of ovarian cancer. It can be caused by different types of mutation, including ...

The ChemoFx® drug response assay is a treatment selection marker for chemotherapies that quantifies an individual cancer patients’ in vitro tumor response to various chemotherapeutic agents. “The drug ...

“These are often complex patterns, where there may not be one biomarker, but you have to take into consideration the whole pattern,” says Dr Petrovski, whose is a researcher at pharmaceuticals giant ...

An FDA committee’s September 2024 vote to limit the use of Merck’s Keytruda and BMS’ Opdivo in stomach and esophageal cancers ...

Ovarian cancer is “rare ... But he says the AI was able to get better accuracy than the best cancer biomarkers that are available today - and that was just the first try. The system is ...